Screening of Latent Tuberculous Infection (LTBI) before starting anti-tumor necrosis factor therapy in patients with psoriasis: A primer for clinical dermatologist

• Κύριοι συγγραφείς: Swetalina Pradhan (Συγγραφέας), Bhushan Madke (Συγγραφέας), Shekhar Neema (Συγγραφέας), Poonam Kabra (Συγγραφέας), Adarsh Lata Singh (Συγγραφέας), Sangita Yadav (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Anti-tumor necrosis agents are being increasingly used in the management of moderate to severe psoriasis. Therapy with antitumor necrosis factor alpha (TNF-α) agents is being fraught with reactivation of latent tuberculosis infection (LTBI). This paper addresses the intricate relation between LTBI a...